Belite Bio, Inc ( BLTE ) Q3 2026 Earnings Call November 12, 2026 4:30 PM EST
Company Participants
Julie Fallon
Yu-Hsin Lin - Chairman of the Board of Directors & CEO
Hao-Yuan Chuang - CFO & Director
Hendrik Scholl - Chief Medical Officer
Conference Call Participants
Maxwell Skor - Morgan Stanley, Research Division
Tazeen Ahmad - BofA Securities, Research Division
Steven Seedhouse - Cantor Fitzgerald & Co., Research Division
Marc Goodman - Leerink Partners LLC, Research Division
Whitney Ijem - Canaccord Genuity Corp., Research Division
Graig Suvannavejh - Mizuho Securities USA LLC, Research Division
Presentation
Operator
Ladies and gentlemen, thank you for joining us, and welcome to the Belite Bio Third Quarter 2026 Earnings Call. [Operator Instructions]
I will now hand the conference over to Julie Fallon. Please go ahead.
Julie Fallon
Good afternoon. Thank you for joining us today. On the call are Dr. Tom Lin, Chairman and CEO of Belite Bio; Dr. Hendrik Scholl, Chief Medical Officer; Dr.…